arrow
R

Riad El Fakih

King Faisal Specialist Hospital and Research Center
H指数:20
被引数:1,596

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Decentralized CAR-T production: clinical, economic, and regulatory perspectives. Worldwide Network for Blood & Marrow Transplantation (WBMT) special article

去中心化CAR-T生产:临床、经济和监管视角。世界血液与骨髓移植网络(WBMT)专题文章

2026-09-240
PRE
Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation in sickle cell disease: a narrative review of safety, engraftment, and graft-versus-host-disease outcomes in adults and high-risk populations

非骨髓清除性及低强度预处理方案在镰状细胞病异基因造血干细胞移植中的应用:对成人和高危人群安全性、植入和移植物抗宿主病结局的叙事综述

2026-07-220
PRE
Twelve-year utilization and outcomes of haploidentical hematopoietic stem cell transplantation (HSCT) in the Eastern Mediterranean (EM) region: A multicenter EMBMT registry analysis

十二年同种异基因造血干细胞移植(HSCT)在东地中海(EM)地区的应用与结果:一项多中心EMBMT注册分析

2026-04-010
PRE
Low-Dose Post-Transplant Cyclophosphamide in Haploidentical Stem Cell Transplantation: A Systematic Review

单倍体相合干细胞移植中低剂量移植后环磷酰胺的应用:一项系统综述

2025-12-030
PRE
Pediatric-inspired (R3) vs. Adult salvage (FA) chemotherapy in relapsed adolescents and young adults (AYA) acute lymphoblastic leukemia (ALL): A comparative outcome analysis

儿科启发式(R3)与成人挽救性(FA)化疗在复发青少年和年轻成人(AYA)急性淋巴细胞白血病(ALL)中的比较结局分析

2025-10-010
OAAI
Outcomes of Adolescent and Young Adult (AYA) patients with Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia Treated with Tisagenlecleucel, real world evidence from the Middle East

中东地区接受Tisagenlecleucel治疗的复发/难治性B细胞急性淋巴细胞白血病青少年和年轻成年(AYA)患者的结局:真实世界证据

2025-07-170
PRE
Correction: Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation

更正:在资源有限国家中,使用非冷冻保存的自体外周血干细胞移植治疗多发性骨髓瘤和淋巴瘤:来自世界骨髓移植联盟的实践考量

2025-06-300
PRE
Setting up a Chimeric Antigen Receptor T Cell Therapy Program: A Framework for Delivery from the Worldwide Network for Blood & Marrow Transplantation

建立嵌合抗原受体T细胞疗法项目:世界造血与骨髓移植网络交付框架

2025-05-230
PRE
Minimal Residual Disease Testing for Diffuse Large B Cell Lymphoma

Atout, M.; Elwaheidi, H.; Maarouf, R.; Albabtain, A.A.; Alhayli, S.; Alshaibani, A.; Aljurf, M.; El Fakih, R. 弥散性大B细胞淋巴瘤微小残留病检测。Clin. Lymphoma Myeloma Leuk. 2025, 25, 750–755. [Google Scholar] [CrossRef]

2025-05-070
OAAI
Outcomes of human leukocyte antigen matched sibling transplant from consanguineous versus non-consanguineous parents, a single center experience

人类白细胞抗原相合同胞移植来自近亲与非近亲父母的结局比较:一项单中心经验

2025-04-290
PRE
Outcomes of Adolescent LBCL Patients Treated With Adult Type Chemotherapy: A Single Center Experience

青少年LBCL患者接受成人型化疗的疗效:一项单中心经验

2025-03-170
PRE
Role of Fiberoptic Bronchoscopy in Decision-Making in the Management of Post-Hematopoietic Stem Cell Transplant Patients Presenting with Pulmonary Infiltrates: A Retrospective Cohort Study

纤维支气管镜在造血干细胞移植后出现肺浸润患者的管理决策中的作用:一项回顾性队列研究

2025-01-180
PRE
Non-Western Real-World Experience of Axi-Cel CAR-T in Refractory/Relapsed B-Cell Lymphoma from a Tertiary Center in Saudi Arabia

沙特阿拉伯一家三级中心中,非西方真实世界经验:Axi-Cel CAR-T在难治性/复发性B细胞淋巴瘤中的应用

BLOOD
IF23.1
2024-11-050
PRE
Real World Data of Glofitamab in Relapsed Refractory Large B-Cell Lymphoma in Non-Western Population from a Tertiary Center in Saudi Arabia

沙特阿拉伯一家三级中心非西方人群中复发难治性大B细胞淋巴瘤的Glofitamab真实世界数据

BLOOD
IF23.1
2024-11-050
PRE
Favorable Outcomes with Bridging Radiation Therapy Prior to Anti-CD19 Chimeric Antigen Receptor T-Cell CART in B Cell Lymphoma, a Report from Saudi Arabia

桥接放射治疗在抗-CD19嵌合抗原受体T细胞(CART)治疗前应用于B细胞淋巴瘤的积极结果:来自沙特阿拉伯的报告

BLOOD
IF23.1
2024-11-050
PRE